Coverage
-
July 08, 2011
Sandoz Inc. and other pharmaceutical companies on Friday settled part of a Massachusetts multidistrict litigation alleging the defendants caused the federal government to overpay for Medicaid reimbursements by reporting inflated drug values.
3 other articles on this case.
View all »